This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.


Our history

The Giovanna Tosi Association to fight cancer was born at the end of 2016 to honor the memory of Dr. Giovanna Tosi, an internationally renowned scientist and teacher at the University of Insubria.

Donate now

Make your donation to the "Giovanna Tosi Association to fight cancer" by bank transfer

Banco BPM
Dip. 0150 ILLASI
N. Conto 000433
IBAN: IT92 L 05034 59490 000000000433
Codice Fiscale: 95087030128

Our Aims

To form and inform the public on the various aspects of cancer from prevention to diagnosis and treatment, from environment-associated causes to epidemiology of cancer.

To help cancer patients at the hospital and home.

To help young investigators to initiate and develop their career as cancer researchers

Defeat cancer: we can, if we work and move together!


Our initiatives

Here are some articles regarding the initiatives of our association.


25 may 2021

The message of President Joe Biden to the AACR for the National Cancer Research Month



8 september 2020

The Europeam Medicines Agency of EU approved durvalumab (anti-PD-L1, Imfinzi) as first line treatment in combination with chemoterapies for small cell lung carcinoma (SCLC).

For complete information, please visit the site:



28 may 2020

FDA Approves Nivolumab Plus Ipilimumab and Chemotherapy for First-Line Treatment of Metastatic NSCLC

For complete information on the approval and protocol of treatment, please visit the FDA web site:



20 may 2020

FDA approves atezolizumab (anti-PD-L1) for first-line treatment of metastatic NSCLC with high PD-L1 expression

For full information, visit the FDA website at:


31 march 2020

FDA approves Durvalumab, an anti-PD-1 antibody, for the treatment of extensive-stage small-cell lung cancer 

For full information, see the URL:


5 march 2020

Cancer Research Institute: new fellowships, deadline 1 april 2020

The CRI Irvington Postdoctoral Fellowship Program provides critical financial support and continued career training to the most promising young scientists in basic and tumor immunology as part of CRI lifesaving work in cancer immunotherapy research

For full information see the URL:


17 may 2019

Cancer Research Institute, international reference center for cancer immunotherapy

Cancer Research Institute (CRI) one of the most prestigious international institutions that supports basic and clinical research on tumor immunotherapy, presents its program, informations and most important news on progress in the field that is a major interest of our Association as well.

To know more about the mission and achievements of the CRI, please visit the website


19 september 2018

Poliovirus Therapy Extends Survival in Recurrent Glioblastoma

A genetically modified poliovirus therapy shows significantly improved long-term survival for patients with recurrent glioblastoma, according to a study published in The New England Journal of Medicine.

Read the comment at:

and the article at:


8 may 2018

Cancer Immunotherapy at the Annual Meeting of the AACR 

Over the past few years, cancer immunotherapy has made substantial progress and become an important treatment option for patients with a variety of cancers. At the 2018 annual meeting of the American Association for Cancer Research, held in Chicago, april 14-18, 2018  Immunotherapy dominated the headlines.

For a brief recap of the meeting please visit the website of CRI at:


18 april 2018

Checkpoint immunotherapy combination approved for first-line treatment of Advanced Kidney Cancer

Read more in our News section




Where to find us:
Chair of General Pathology and Immunology
School of Medicine, University of Insubria
Padiglione Biffi
Via Ottorino Rossi 9, 21100 Varese
Tel. + 39-348-3034698

Copyright © Associazionegiovannatosi 2024. All Rights Reserved.